Both in Pharmaceuticals
Arbutus Biopharma vs CryoPort
Over the past year ABUS returned −14.3% and CYRX returned +82.8%; their daily moves had a correlation of 0.25.
ABUS −14.3% CYRX +82.8%Growth of $1, one year, split-adjusted
| Metric | ABUS | CYRX |
|---|---|---|
| Price | $3.93 | $16.53 |
| Market cap | $777.6M | $837.0M |
| Today | −1.88% | +1.82% |
| 1 month | −16.0% | −8.9% |
| 6 months | −10.8% | +35.6% |
| Year to date | −18.4% | +72.1% |
| 1 year | −17.0% | +78.8% |
| Revenue growth (YoY) | −90.6% | +7.7% |
| Gross margin | 100.0% | 46.6% |
| Net margin | −512.0% | −20.9% |
| P/E (TTM) | 5.1× | — |
| Price / sales | 4.3× | 4.5× |
| Net cash | $89.5M | $208.7M |
| Dividend yield | — | — |
| Volatility (60d) | 36.9% | 40.3% |
| Short % of float | 15.6% | 5.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).